Stock Insight Alerts: Pfizer, ADTRAN, GeoEye, Skyworks, Potash Corp.

Pfizer Inc. (NYSE:PFE): Leerink says the FDA’s Arthritis Advisory Committee on May 9 to discuss Pfizer’s tofacitinib is in-line with its expectations. Leerink says the requirement for a panel is no surprise and that it expects the documents for the meeting to be controversial.

ADTRAN Inc. (NASDAQ:ADTN): Adtran mentioned positively at Wedge Partners.

GeoEye, Inc. (NASDAQ:GEOY): Benchmark Co. expects Geoeye to report in-line Q4 results on March 12 but thinks the company’s guidance for FY12 could be weaker than expected. The firm is also concerned about a potential satellite launch push out and keeps a Hold rating on the stock.

Skyworks Solutions Inc. (NASDAQ:SWKS): After meeting with Skyworks, DA Davidson increased its target on the company, as the firm believes that the company is well-positioned for further growth. The firm believes that the company may beat estimates and it reiterates a Buy rating.

Potash Corp. of Saskatchewan, Inc. (NYSE:POT): After speaking with fertilizer dealers, Citigroup reports that the dealers expect pricing momentum for several types of fertilizers to be soft during the summer. The firm expects fertilizer sales to be fine during the Spring, but lose momentum during the Summer.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com